Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer: A case report.

about

Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer: A case report.

Item

http://www.wikidata.org/entity/Q55403719

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@en

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@nl

type

Item

label

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@en

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@nl

prefLabel

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@en

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@nl

P1476

Alloreactive cytotoxic T lymph ...... rostate cancer: A case report.

@en

P2093

Huanyu Zhao

http://www.w3.org/2001/XMLSchema#string

Hui Sun

http://www.w3.org/2001/XMLSchema#string

Jinfei Chen

http://www.w3.org/2001/XMLSchema#string

Junfeng Shi

http://www.w3.org/2001/XMLSchema#string

Yi Chen

http://www.w3.org/2001/XMLSchema#string

Yuetong Chen

http://www.w3.org/2001/XMLSchema#string

Yunzhu Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Gene therapy for prostate cancer: current status and future prospects.

A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.

Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer.

Dendritic cells and cytokines in immune rejection of cancer.

Dendritic cell homeostasis.

Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain

VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer.

P304

e11111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000011111

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29901632

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

lymphocyte

P932

6023702

http://www.w3.org/2001/XMLSchema#string